FUNCTIONAL ANALYSIS OF ACTIVINS DURING DEVELOPMENT

发育过程中激活素的功能分析

基本信息

  • 批准号:
    6476789
  • 负责人:
  • 金额:
    $ 25.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-08-17 至 2004-05-31
  • 项目状态:
    已结题

项目摘要

In mammals, there are approximately 100,000 genes which govern the development of an organism. For development to proceed normally, there must be coordinate interaction of tens of thousands of these gene products in any given cell of the being. Beginning with fertilization, precise expression of these gene products is required during embryonic, fetal, postnatal, and adult development. Aberrant synthesis of even one of these gene products can be disastrous - birth defects, cancer, infertility, and even death are all possible when this developmental program is altered. To fully understand these processes in humans, it is necessary to have physiological models that closely mimic developmental events which occur during the creation of a human being. Toward this end, we have chosen the mouse as the mammalian model for our studies. It is now possible to modify the mouse genome to generate strains of mice with precise genetic mutations. Using this technology, our laboratory has created several models which have birth defects. For example, mice with mutations in the activin betaA and follistatin genes die at birth and have cleft palate, a common birth defect in humans of unknown etiology. In addition, mice a mutations in the activin receptor type II gene have skeletal and facial abnormalities which mimic the human Pierre-Robin syndrome; human newborns with this syndrome have defects in the mandible, leading to respiratory distress which must be surgically corrected immediately. In this grant proposal, we will utilize these previously created mouse models as well as additional models (i.e., mice lacking activins betaC an betaE) to study this complex signal transduction system. The Specific Aims are: 1) Define the functions of the liver-specific TGF-beta-superfamily members, activins betaC and betaE; 2) Perform an activin betaB "knockin" to attempt a rescue of activin betaA knockout mice; and 3) Study the postnatal functions of follistatin and activin betaA using inducible knockout systems. Future studies using these mice as in vivo mammalian model systems will enable us to more fully understand the interrelated roles of these proteins in mammalian development and physiology.
在哺乳动物中,大约有10万个基因控制着身体的发育

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN M. MATZUK其他文献

MARTIN M. MATZUK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN M. MATZUK', 18)}}的其他基金

Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
  • 批准号:
    10682061
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Kinases as Therapeutic Targets for Endometriosis
激酶作为子宫内膜异位症的治疗靶点
  • 批准号:
    10674987
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
  • 批准号:
    10764639
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
  • 批准号:
    10419647
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
使用特定 KLK3 抑制剂作为新避孕药破坏精液液化
  • 批准号:
    10598585
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Kinases as Therapeutic Targets for Endometriosis
激酶作为子宫内膜异位症的治疗靶点
  • 批准号:
    10532966
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Targeting testis-specific ubiquitin-proteasome pathways for male contraception
针对男性避孕的睾丸特异性泛素蛋白酶体途径
  • 批准号:
    10018522
  • 财政年份:
    2019
  • 资助金额:
    $ 25.88万
  • 项目类别:
Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
功能基因组学和 DEC-Tec 鉴定生殖细胞特异性避孕药
  • 批准号:
    10164823
  • 财政年份:
    2017
  • 资助金额:
    $ 25.88万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9278437
  • 财政年份:
    2017
  • 资助金额:
    $ 25.88万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10164824
  • 财政年份:
    2017
  • 资助金额:
    $ 25.88万
  • 项目类别:

相似国自然基金

Follistatin调控脊椎动物左右不对称发育的机制研究
  • 批准号:
    31970757
  • 批准年份:
    2019
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Activin/follistatin信号系统对中华鲟卵巢发育的调控及作用机制
  • 批准号:
    31802282
  • 批准年份:
    2018
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
祛瘀生肌法通过Follistatin/Activin信号通路改善糖尿病溃疡炎症微环境的相关机制研究
  • 批准号:
    81673866
  • 批准年份:
    2016
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
Follistatin与连续性牙齿(Successional Teeth)发育的遗传学控制
  • 批准号:
    81570941
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
调控Follistatin基因促进全身骨骼肌细胞增生及改善运动功能的研究
  • 批准号:
    81100938
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
Activin和Follistatin基因在不同倍性鲫鲤的表达及育性相关性研究
  • 批准号:
    31001105
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
牙鲆Follistatin 和Myostatin基因的克隆及其表达和功能分析
  • 批准号:
    30871929
  • 批准年份:
    2008
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目

相似海外基金

NSF PRFB FY 2023: Investigating enhancer and protein divergence at follistatin paralogs underlying genetic assimilation of wing plasticity
NSF PRFB 2023 财年:研究卵泡抑素旁系同源物的增强子和蛋白质差异,这些是翅膀可塑性遗传同化的基础
  • 批准号:
    2305817
  • 财政年份:
    2023
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Fellowship Award
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
类卵泡抑素 1 介导细菌性肺炎中的宿主防御
  • 批准号:
    10636904
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Investigating the Mechanism Through Which Follistatin Affects Vessel Contractility in Essential Hypertension
研究卵泡抑素影响原发性高血压血管收缩性的机制
  • 批准号:
    486253
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
    Studentship Programs
Follistatin regulation of energy and lipid metabolism during progression of atherosclerosis
卵泡抑素对动脉粥样硬化进展过程中能量和脂质代谢的调节
  • 批准号:
    10412836
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
Follistatin regulation of energy and lipid metabolism during progression of atherosclerosis
卵泡抑素对动脉粥样硬化进展过程中能量和脂质代谢的调节
  • 批准号:
    10618987
  • 财政年份:
    2022
  • 资助金额:
    $ 25.88万
  • 项目类别:
The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea
LIN28B 和卵泡抑素在支持小鼠耳蜗细胞重编程和毛细胞再生中的功能
  • 批准号:
    10513325
  • 财政年份:
    2021
  • 资助金额:
    $ 25.88万
  • 项目类别:
The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea
LIN28B 和卵泡抑素在支持小鼠耳蜗细胞重编程和毛细胞再生中的功能
  • 批准号:
    10366493
  • 财政年份:
    2021
  • 资助金额:
    $ 25.88万
  • 项目类别:
The Role of Follistatin Like Protein 1 in the cardiac inflammation of Kawasaki Disease
卵泡抑素样蛋白1在川崎病心脏炎症中的作用
  • 批准号:
    10091126
  • 财政年份:
    2021
  • 资助金额:
    $ 25.88万
  • 项目类别:
The Role of Follistatin Like Protein 1 in the cardiac inflammation of Kawasaki Disease
卵泡抑素样蛋白1在川崎病心脏炎症中的作用
  • 批准号:
    10322089
  • 财政年份:
    2021
  • 资助金额:
    $ 25.88万
  • 项目类别:
The Role of Follistatin Like Protein 1 in the cardiac inflammation of Kawasaki Disease
卵泡抑素样蛋白1在川崎病心脏炎症中的作用
  • 批准号:
    10543843
  • 财政年份:
    2021
  • 资助金额:
    $ 25.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了